ATE455117T1 - 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren - Google Patents

5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren

Info

Publication number
ATE455117T1
ATE455117T1 AT05856357T AT05856357T ATE455117T1 AT E455117 T1 ATE455117 T1 AT E455117T1 AT 05856357 T AT05856357 T AT 05856357T AT 05856357 T AT05856357 T AT 05856357T AT E455117 T1 ATE455117 T1 AT E455117T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
hepatitis
diüpyrimidine
fighting
viruses
Prior art date
Application number
AT05856357T
Other languages
English (en)
Inventor
Cheol Kyu Han
Jeonghyeok Yoon
Nam-Doo Kim
Jin-Ah Kim
Original Assignee
Equispharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Equispharm Co Ltd filed Critical Equispharm Co Ltd
Application granted granted Critical
Publication of ATE455117T1 publication Critical patent/ATE455117T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05856357T 2005-09-23 2005-09-23 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren ATE455117T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2005/003172 WO2007035010A2 (en) 2005-09-23 2005-09-23 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus

Publications (1)

Publication Number Publication Date
ATE455117T1 true ATE455117T1 (de) 2010-01-15

Family

ID=37889268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05856357T ATE455117T1 (de) 2005-09-23 2005-09-23 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren

Country Status (8)

Country Link
US (1) US7816351B2 (de)
EP (1) EP1928884B1 (de)
JP (1) JP4767321B2 (de)
CN (1) CN101268081B (de)
AT (1) ATE455117T1 (de)
AU (1) AU2005336552B2 (de)
DE (1) DE602005018972D1 (de)
WO (1) WO2007035010A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2467007C2 (ru) 2005-12-21 2012-11-20 Эбботт Лэборетриз Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv
ES2395386T3 (es) 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
RU2441869C2 (ru) 2005-12-21 2012-02-10 Эбботт Лэборетриз Противовирусные соединения
RU2441010C2 (ru) * 2005-12-21 2012-01-27 Эбботт Лэборетриз Противовирусные соединения
CA2672737A1 (en) 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
CN102971327B (zh) * 2010-05-26 2016-04-20 韩国科学技术研究院 具有多种酪氨酸激酶抑制活性的抗炎化合物以及含有这些化合物的药物组成物
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
US10220034B2 (en) 2013-10-18 2019-03-05 Indiana University Research And Technology Corporation Hepatitis B viral assembly effectors
US10273228B2 (en) 2015-04-17 2019-04-30 Indiana University Research And Technology Corporation Hepatitis B viral assembly effectors
EP3394056B1 (de) 2015-12-22 2021-04-14 Shy Therapeutics LLC Verbindungen zur behandlung von krebs und entzündungskrankheiten
CA3066939A1 (en) * 2017-06-21 2018-12-27 SHY Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US12391705B2 (en) 2018-12-19 2025-08-19 Shy Therapeutics, Llc Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
JPS58225089A (ja) * 1982-06-25 1983-12-27 Sankyo Co Ltd チエノピリミジン誘導体およびその製造法
EP0082023A3 (de) 1981-12-16 1983-07-20 Sankyo Company Limited Thienopyrimidinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
EP0948135B1 (de) 1998-03-31 2004-08-11 STMicroelectronics S.r.l. Generator von Pulsen mit programmierbarer Dauer
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
BRPI0408284B8 (pt) 2003-03-12 2021-05-25 Kudos Pharm Ltd compostos derivados de ftalazinona, seu uso e composição farmacêutica compreendendo os mesmos
DE10351436A1 (de) 2003-11-04 2005-06-09 Merck Patent Gmbh Verwendung von Thienopyrimidinen

Also Published As

Publication number Publication date
EP1928884A2 (de) 2008-06-11
US20080234482A1 (en) 2008-09-25
EP1928884A4 (de) 2008-11-12
JP4767321B2 (ja) 2011-09-07
EP1928884B1 (de) 2010-01-13
US7816351B2 (en) 2010-10-19
AU2005336552A1 (en) 2007-03-29
WO2007035010A2 (en) 2007-03-29
CN101268081A (zh) 2008-09-17
JP2009508939A (ja) 2009-03-05
WO2007035010A3 (en) 2007-05-24
AU2005336552B2 (en) 2010-09-16
DE602005018972D1 (de) 2010-03-04
CN101268081B (zh) 2010-12-29

Similar Documents

Publication Publication Date Title
WO2006046030A3 (en) Tetracyclic indole derivatives as antiviral agents
WO2007029029A3 (en) Tetracyclic indole derivatives as antiviral agents
EP2041159B8 (de) Makrozyklische verbindungen als antivirale mittel
WO2002100851A3 (en) Thiophene derivatives as antiviral agents for flavivirus infection
WO2007112028A3 (en) 2'-fluoronucleoside phosphonates as antiviral agents
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
PL366726A1 (en) 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
WO2008021928A3 (en) Hepatitis c virus inhibitors
WO2004113365A3 (en) Hepatitis c serine protease tri-peptide inhibitors
WO2005063744A3 (en) IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
ATE383360T1 (de) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h- pyrido(2,3-d)pyrimidinderivate und verwandte verbindungen zur behandlung von krebs
EP2368900A3 (de) Inhibitoren der Serinproteasen, insbesondere der HCV-NS3-NS4A-Protease
MXPA06000418A (es) Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral.
ATE373005T1 (de) Thienopyrrole als antivirale mittel
ATE455117T1 (de) 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
WO2024076951A3 (en) Antiviral prodrugs and formulations thereof
ZA200900165B (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
EA200100725A3 (ru) Новые бензотиадиазиновые соединения, способ их получения и их содержащие фармацевтические композиции
TW200626567A (en) Benzoxazine and quinoxaline derivatives and uses
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
MXPA05010957A (es) Derivados de ornitina activos farmaceuticamente, sales de amonio de los mismos y metodos para su preparacion.
ATE370122T1 (de) 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung
CA2534558A1 (en) Ammonium salts of ornithine derivatives for treating inflammatory diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties